+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence and Clinical Impact of Stent Fractures After Femoropopliteal Stenting



Prevalence and Clinical Impact of Stent Fractures After Femoropopliteal Stenting



Yearbook of Vascular Surgery 2007: 214-215




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063602764

Download citation: RISBibTeXText

DOI: 10.1016/s0749-4041(08)70504-9


Related references

Prevalence and clinical impact of stent fractures after femoropopliteal stenting. Journal of the American College of Cardiology 45(2): 312-315, 2005

Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. European Journal of Vascular and Endovascular Surgery 46(2): 201-212, 2013

Biochemical and molecular characterisation of exogenous cytokinin application on grain filling in rice. Bmc Plant Biology 18(1): 89, 2018

Impact of stent fractures following femoropopliteal stenting. Journal of the American College of Cardiology 46(10): 1961-1961, 2005

Two-year clinical outcomes of stent fractures following primary femoropopliteal stenting. European Journal of Vascular and Endovascular Surgery 46(5): 601, 2013

Prevalence, factors, and clinical impact of self-expanding stent fractures following iliac artery stenting. Journal of Vascular Surgery 49(3): 645-652, 2009

Clinical impact of self-expandable stent diameter after femoropopliteal stenting. Cardiovascular Intervention and Therapeutics 26(1): 38-44, 2011

Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent: a single-center study. Journal of Cardiovascular Medicine 11(9): 678-682, 2010

Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP). Catheterization and Cardiovascular Interventions 90(5): 790-797, 2017

Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. Journal of Vascular Surgery 52(3): 608-615, 2010

Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. Journal of Endovascular Therapy 12(6): 676-684, 2005

Classification and clinical impact of restenosis after femoropopliteal stenting. Journal of the American College of Cardiology 59(1): 16-23, 2012

The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatation. Eurointervention 2(4): 459-466, 2007

Clinical impact of bisoprolol versus carvedilol in patients undergoing femoropopliteal stenting. Journal of Atherosclerosis and Thrombosis 21(7): 691-702, 2014

Stent fractures after superficial femoral artery stenting: risk factors and impact on patency. Journal of Endovascular Therapy 22(3): 319-326, 2015